Related Experiment Video

Updated: May 3, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

11.1K

β-diketone-cobalt complexes inhibit DNA synthesis and induce S-phase arrest in rat C6 glioma cells

Kaizhi Zhang1, Xingli Zhao1, Junzhi Liu1

  • 1China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China.

Oncology Letters
|February 13, 2014
PubMed

Insights

Newly developed beta-diketone-cobalt complexes effectively inhibit rat C6 glioma cell growth by halting DNA synthesis and cell cycle progression. These compounds show greater antitumor potential than 5-fluorouracil.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Beta-diketone-cobalt complexes are novel non-platinum metal compounds with potential antitumor activity.
  • The precise mechanism of action for these complexes in cancer treatment remains largely unelucidated.
  • Understanding the molecular pathways targeted by these compounds is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the mechanism by which beta-diketone-cobalt complexes inhibit rat C6 glioma cell proliferation.
  • To determine the dose-dependent effects and cytotoxic concentrations (IC50, IC10) of these complexes.
  • To compare the antitumor efficacy of beta-diketone-cobalt complexes with a standard chemotherapeutic agent, 5-fluorouracil.

Main Methods:

  • Cell viability assays were performed on rat C6 glioma cells treated with varying concentrations of beta-diketone-cobalt complexes.
  • Cell cycle analysis was conducted to identify potential arrest points and effects on DNA synthesis.
  • Expression levels of key cell cycle regulatory proteins (cyclin A, cyclin E, p21) were assessed.

Main Results:

  • Beta-diketone-cobalt complexes demonstrated a dose-dependent suppression of rat C6 glioma cell viability, with an IC50 of 24.7±3.395 μg/ml.
  • The complexes induced S-phase arrest and inhibited DNA synthesis in the treated cells.
  • Treatment led to decreased cyclin A expression and increased cyclin E and p21 expression, indicating cell cycle dysregulation.
  • Beta-diketone-cobalt complexes exhibited superior antitumor activity compared to 5-fluorouracil.

Conclusions:

  • Beta-diketone-cobalt complexes effectively inhibit rat C6 glioma cell proliferation through mechanisms involving S-phase arrest and DNA synthesis inhibition.
  • The modulation of cyclin A, cyclin E, and p21 expression underscores the cell cycle-disrupting effects of these compounds.
  • These novel complexes represent a promising alternative or adjunct to existing chemotherapies like 5-fluorouracil for glioma treatment.
Keywords:
DNA synthesiscell cyclegliomaβ-diketone-cobalt complexes

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.7K

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
130
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K